{"id":74258,"date":"2025-03-16T06:27:08","date_gmt":"2025-03-16T05:27:08","guid":{"rendered":"https:\/\/www.infokuryr.cz\/n\/?p=74258"},"modified":"2025-03-16T06:27:08","modified_gmt":"2025-03-16T05:27:08","slug":"prulomova-studie-zjistila-ze-obycejny-acylpyrin-dokaze-zastavit-sireni-rakoviny-prsu-prostaty-a-tlusteho-streva","status":"publish","type":"post","link":"https:\/\/www.infokuryr.cz\/n\/2025\/03\/16\/prulomova-studie-zjistila-ze-obycejny-acylpyrin-dokaze-zastavit-sireni-rakoviny-prsu-prostaty-a-tlusteho-streva\/","title":{"rendered":"Pr\u016flomov\u00e1 studie zjistila, \u017ee oby\u010dejn\u00fd acylpyrin dok\u00e1\u017ee zastavit \u0161\u00ed\u0159en\u00ed rakoviny prsu, prostaty a tlust\u00e9ho st\u0159eva"},"content":{"rendered":"
<\/div>\n

V pozoruhodn\u00e9m zvratu v\u011bdeck\u00e9ho b\u00e1d\u00e1n\u00ed v\u00fdzkumn\u00edci odhalili, jako aspirin, b\u011b\u017en\u00fd voln\u011b prodejn\u00fd l\u00e9k proti bolesti, m\u016f\u017ee pomoci zpomalit \u0161\u00ed\u0159en\u00ed ur\u010dit\u00fdch druh\u016f rakoviny, v\u010detn\u011b rakoviny prsu, tlust\u00e9ho st\u0159eva a prostaty.<\/strong><\/p>\n

Objev publikovan\u00fd v presti\u017en\u00edm v\u011bdeck\u00e9m \u010dasopise\u00a0<\/span>Nature<\/span><\/em> vrh\u00e1 sv\u011btlo na to, jak tento l\u00e9k zvy\u0161uje schopnost imunitn\u00edho syst\u00e9mu bojovat proti rakovinn\u00fdm bu\u0148k\u00e1m. Jedn\u00e1 se o zji\u0161t\u011bn\u00ed, kter\u00e9 by mohlo v\u00e9st k dostupn\u011bj\u0161\u00ed a n\u00e1kladov\u011b efektivn\u011bj\u0161\u00ed l\u00e9\u010db\u011b pro pacienty na cel\u00e9m sv\u011bt\u011b.<\/span><\/p>\n

Pr\u016flom nastal ne\u010dekan\u011b, kdy\u017e v\u011bdci z\u00a0<\/span>Cambridgesk\u00e9 univerzity<\/span><\/em>\u00a0zkoumali, jak imunitn\u00ed syst\u00e9m reaguje na rakovinu. Zjistili, \u017ee aspirin blokuje chemickou l\u00e1tku zvanou tromboxan A2 (TXA2), kterou produkuj\u00ed krevn\u00ed desti\u010dky.<\/span><\/p>\n

L\u00e1tka TXA2 oslabuje t\u011blesn\u00e9 T-bu\u0148ky, typ imunitn\u00edch bun\u011bk, kter\u00e9 jsou rozhoduj\u00edc\u00ed pro napaden\u00ed rakoviny. Inhibic\u00ed l\u00e1tky TXA2 aspirin v podstat\u011b \u201euvol\u0148uje ruce\u201c T-bu\u0148k\u00e1m, co\u017e jim umo\u017e\u0148uje efektivn\u011bji zac\u00edlit a ni\u010dit rakovinov\u00e9 bu\u0148ky.<\/span><\/p>\n

\u201eByl to Heur\u00e9ka moment,\u201c<\/span><\/em>\u00a0\u0159ekl Dr. Jie Yang, vedouc\u00ed v\u00fdzkumn\u00edk studie.<\/span><\/p>\n

\u201eZpo\u010d\u00e1tku jsme se na acylpyrin ani nepod\u00edvali, ale tento objev n\u00e1s poslal na zcela novou cestu zkoum\u00e1n\u00ed.\u201c<\/span><\/em><\/p>\n

Dlouh\u00e1 historie potenci\u00e1lu acylpyrinu<\/span><\/h2>\n

Potenci\u00e1l acylpyrinu v boji proti rakovin\u011b nen\u00ed zcela nov\u00fd. Ji\u017e p\u0159edchoz\u00ed studie nazna\u010dily jeho p\u0159\u00ednosy.<\/span><\/p>\n

Anal\u00fdza z roku 2021 na v\u00edce ne\u017e 140 000 pacientech s rakovinou prsu zjistila, \u017ee pravideln\u00e9 u\u017e\u00edv\u00e1n\u00ed acylpyrinu bylo spojeno s 31% sn\u00ed\u017een\u00edm \u00famrtnosti na rakovinu a 9% sn\u00ed\u017een\u00edm rizika recidivy nebo metast\u00e1z.<\/span><\/p>\n

Podobn\u011b studie z roku 2020 uk\u00e1zala, \u017ee acylpyrin sni\u017euje riziko\u00a0<\/span>rakoviny tlust\u00e9ho st\u0159eva<\/span><\/a>\u00a0o v\u00edce ne\u017e 25%.<\/span><\/p>\n

Doposud v\u0161ak z\u016fst\u00e1val mechanismus za t\u011bmito \u00fa\u010dinky nejasn\u00fd. Nov\u00fd v\u00fdzkum nejen vysv\u011btluje, jak aspirin funguje, ale tak\u00e9 zd\u016fraz\u0148uje jeho potenci\u00e1l zabr\u00e1nit \u0161\u00ed\u0159en\u00ed rakoviny \u2013 co\u017e je kritick\u00fd faktor p\u0159i sni\u017eov\u00e1n\u00ed \u00famrt\u00ed souvisej\u00edc\u00edch s rakovinou.<\/span><\/p>\n

Metast\u00e1zov\u00e1n\u00ed je proces, kter\u00fdm se rakovina \u0161\u00ed\u0159\u00ed do jin\u00fdch \u010d\u00e1st\u00ed t\u011bla a je zodpov\u011bdn\u00e9 za 90% \u00famrt\u00ed na rakovinu.<\/span><\/p>\n

Okno p\u0159\u00edle\u017eitosti<\/span><\/h2>\n

Studie nazna\u010duje, \u017ee acylpyrin by mohl b\u00fdt obzvl\u00e1\u0161t\u011b \u00fa\u010dinn\u00fd v \u010dasn\u00fdch st\u00e1di\u00edch rakoviny, kdy jsou bu\u0148ky nejzraniteln\u011bj\u0161\u00ed v\u016f\u010di imunitn\u00edmu \u00fatoku.<\/span><\/p>\n

\u201eKdy\u017e rakovina poprv\u00e9 vznikne, je zde jedine\u010dn\u00e9 terapeutick\u00e9 okno p\u0159\u00edle\u017eitosti<\/span><\/em>\u00a0,\u201c \u0159\u00edk\u00e1 profesor Rahul Roychoudhuri, hlavn\u00ed autor studie.\u00a0<\/span>\u201eTerapie, kter\u00e9 se zam\u011b\u0159uj\u00ed na toto okno, mohou m\u00edt obrovsk\u00fd v\u00fdznam p\u0159i prevenci recidivy.\u201c<\/span><\/em><\/p>\n

Tento objev m\u00e1 potenci\u00e1l u\u010dinit z aspirinu cenn\u00fd n\u00e1stroj v boji proti rakovin\u011b, zejm\u00e9na v prost\u0159ed\u00ed s n\u00edzk\u00fdmi p\u0159\u00edjmy.<\/span><\/p>\n

\u201eAspirin nebo jin\u00e9 l\u00e9ky, kter\u00e9 jsou zam\u011b\u0159eny na tento \u00fa\u010dinek, maj\u00ed potenci\u00e1l b\u00fdt levn\u011bj\u0161\u00ed ne\u017e terapie zalo\u017een\u00e9 na protil\u00e1tk\u00e1ch, proto budou i glob\u00e1ln\u011b dostupn\u011bj\u0161\u00ed,\u201c<\/span><\/em>\u00a0dodal Dr. Yang.<\/span><\/p>\n

Je zapot\u0159eb\u00ed dal\u0161\u00edho v\u00fdzkumu<\/span><\/h2>\n

Zat\u00edmco uveden\u00e1 zji\u0161t\u011bn\u00ed jsou slibn\u00e1, odborn\u00edci varuj\u00ed p\u0159ed samol\u00e9\u010dbou aspirinem. P\u0159\u00edpravek nen\u00ed bez rizik a vedlej\u0161\u00edch \u00fa\u010dink\u016f, v\u010detn\u011b rizika vnit\u0159n\u00edho krv\u00e1cen\u00ed a \u017ealude\u010dn\u00edch v\u0159ed\u016f.<\/span><\/p>\n

\u201eJe d\u016fle\u017eit\u00e9 pochopit, kte\u0159\u00ed pacienti budou m\u00edt nejv\u011bt\u0161\u00ed u\u017eitek a v\u017edy si promluvit se sv\u00fdm l\u00e9ka\u0159em d\u0159\u00edve, ne\u017e za\u010dnete u\u017e\u00edvat acylpyrin,\u201c<\/span><\/em>\u00a0\u0159\u00edk\u00e1 profesorka Ruth Langleyov\u00e1, kter\u00e1 vede samostatnou klinickou studii o \u00fa\u010dinc\u00edch acylpyrinu na rakovinu.<\/span><\/p>\n

Dal\u0161\u00ed kroky zahrnuj\u00ed rozs\u00e1hl\u00e9 klinick\u00e9 studie s c\u00edlem ur\u010dit, kter\u00e9 typy rakoviny a skupiny pacient\u016f by m\u011bly z l\u00e9\u010dby acylpyrinem nejv\u011bt\u0161\u00ed u\u017eitek.<\/span><\/p>\n

V\u00fdzkumn\u00edci tak\u00e9 zkoumaj\u00ed v\u00fdvoj nov\u00fdch l\u00e9k\u016f, kter\u00e9 napodobuj\u00ed zdravotn\u00ed p\u0159\u00ednosy acylpyrinu, ale bez jeho vedlej\u0161\u00edch \u00fa\u010dink\u016f.<\/span><\/p>\n

Z\u00e1v\u011br<\/span><\/h2>\n

Tento n\u00e1hodn\u00fd objev podtrhuje d\u016fle\u017eitost v\u00fdzkumu zalo\u017een\u00e9ho na zv\u011bdavosti a ukazuje potenci\u00e1l, jako\u017e i b\u011b\u017en\u00e9 l\u00e9ky mohou m\u00edt \u017eivot zachra\u0148uj\u00edc\u00ed aplikace.<\/span><\/p>\n

P\u0159esto\u017ee acylpyrin nen\u00ed l\u00e9k na v\u0161echno, jeho schopnost pos\u00edlit imunitn\u00ed syst\u00e9m v boji proti rakovin\u011b nab\u00edz\u00ed z\u00e1blesk nad\u011bje pro miliony pacient\u016f na cel\u00e9m sv\u011bt\u011b.<\/span><\/p>\n

Autor: Cassie B., Zdruj:\u00a0<\/span>naturalnews.com<\/span><\/a>\u00a0<\/span><\/p>\n

 <\/p>\n","protected":false},"excerpt":{"rendered":"

V pozoruhodn\u00e9m zvratu v\u011bdeck\u00e9ho b\u00e1d\u00e1n\u00ed v\u00fdzkumn\u00edci odhalili, jako aspirin, b\u011b\u017en\u00fd voln\u011b prodejn\u00fd l\u00e9k proti bolesti,…<\/p>\n","protected":false},"author":2,"featured_media":74259,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[7],"tags":[8716,1366,839,21],"_links":{"self":[{"href":"https:\/\/www.infokuryr.cz\/n\/wp-json\/wp\/v2\/posts\/74258"}],"collection":[{"href":"https:\/\/www.infokuryr.cz\/n\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.infokuryr.cz\/n\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.infokuryr.cz\/n\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.infokuryr.cz\/n\/wp-json\/wp\/v2\/comments?post=74258"}],"version-history":[{"count":0,"href":"https:\/\/www.infokuryr.cz\/n\/wp-json\/wp\/v2\/posts\/74258\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.infokuryr.cz\/n\/wp-json\/wp\/v2\/media\/74259"}],"wp:attachment":[{"href":"https:\/\/www.infokuryr.cz\/n\/wp-json\/wp\/v2\/media?parent=74258"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.infokuryr.cz\/n\/wp-json\/wp\/v2\/categories?post=74258"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.infokuryr.cz\/n\/wp-json\/wp\/v2\/tags?post=74258"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}